Effectiveness and safety of community-based treatment with sofosbuvir plus ribavirin for elderly patients with genotype 2 chronic hepatitis C.
暂无分享,去创建一个
A. Tsubota | Etsuko Iio | Yasuhito Tanaka | K. Iwakiri | N. Shimada | M. Atsukawa | Keizo Kato | N. Itokawa | H. Abe | T. Okubo | Taeang Arai | C. Kondo | T. Arai